Clinical investigation of Chemotherapeutic Resistance and miRNA expressions in head and neck cancers: A thorough PRISMA compliant systematic review and comprehensive meta-analysis

Jayaraj, Rama, Polpaya, Karthikbinu, Kunale, Milind, Muthukaliannan, Gothandam Kodiveri, Shetty, Sameep, Baxi, Siddhartha, Mani, Ravishankar Ram, Paranjothy, Chitraabaanu, Purushothaman, Vinosh, Kayarohanam, Saminathan, Janakiraman, Ashok Kumar and Balaraman, Ashok Kumar (2022) Clinical investigation of Chemotherapeutic Resistance and miRNA expressions in head and neck cancers: A thorough PRISMA compliant systematic review and comprehensive meta-analysis. Genes, 13 (12): 2325. ISSN 2073-4425

[thumbnail of Clinical Investigation of Chemotherapeutic.pdf] Text
Clinical Investigation of Chemotherapeutic.pdf - Published Version

Download (1MB)


Chemoresistance is a significant barrier to combating head and neck cancer, and decoding this resistance can widen the therapeutic application of such chemotherapeutic drugs. This systematic review and meta-analysis explores the influence of microRNA (miRNA) expressions on chemoresistance in head and neck cancers (HNC). The objective is to evaluate the theragnostic effects of microRNA expressions on chemoresistance in HNC patients and investigate the utility of miRNAs as biomarkers and avenues for new therapeutic targets. Methods: We performed a comprehensive bibliographic search that included the SCOPUS, PubMed, and Science Direct bibliographic databases. These searches conformed to a predefined set of search strategies. Following the PRISMA guidelines, inclusion and exclusion criteria were framed upon completing the literature search. The data items extracted were tabulated and collated in MS Excel. This spreadsheet was used to determine the effect size estimation for the theragnostic effects of miRNA expressions on chemoresistance in HNC, the hazard ratio (HR), and 95% confidence intervals (95% CI). The comprehensive meta-analysis was performed using the random effects model. Heterogeneity among the data collected was assessed using the Q test, Tau2, I2, and Z measures. Publication bias of the included studies was checked using the Egger’s bias indicator test, Orwin and classic fail-safe N test, Begg and Mazumdar rank collection test, and Duval and Tweedie’s trim and fill methods. Results: After collating the data from 23 studies, dysregulation of 34 miRNAs was observed in 2189 people. These data were gathered from 23 studies. Out of the 34 miRNAs considered, 22 were up-regulated, while 12 were down-regulated. The TaqMan transcription kits were the most used miRNA profiling platform, and miR-200c was seen to have a mixed dysregulation. We measured the overall pooled effect estimate of HR to be 1.516 for the various analyzed miRNA at a 95% confidence interval of 1.303–1.765, with a significant p-value. The null hypothesis test’s Z value was 5.377, and the p-value was correspondingly noted to be less than 0.0001. This outcome indicates that the risk of death is determined to be higher in up-regulated groups than in down-regulated groups. Among the 34 miRNAs that were investigated, seven miRNAs were associated with an improved prognosis, especially with the overexpression of these seven miRNAs (miR15b-5p, miR-548b, miR-519d, miR-1278, miR-145, miR-200c, Hsa- miR139-3p). Discussion: The findings reveal that intricate relationships between miRNAs’ expression and chemotherapeutic resistance in HNC are more likely to exist and can be potential therapeutic targets. This review suggests the involvement of specific miRNAs as predictors of chemoresistance and sensitivity in HNC. The examination of the current study results illustrates the significance of miRNA expression as a theragnostic biomarker in medical oncology.

Item Type: Article
Keywords: Chemoresistance | Down-Regulation | Hazard Ratio | Head and Neck Cancer (HNC) | miRNA | Patient Survival | PRISMA | Prognosis | Protocol | Systematic Review | Up-Regulation
Subjects: Social Sciences and humanities > Social Sciences > Social Sciences (General)
JGU School/Centre: Jindal Institute of Behavioural Sciences
Depositing User: Amees Mohammad
Date Deposited: 02 Jan 2023 05:50
Last Modified: 02 Jan 2023 05:50
Official URL:


Downloads per month over past year

Actions (login required)

View Item
View Item